EUVIMEDSkopri EUVIMED
Crossref

Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site

Xiangkai Kong, Yu Su, Siyu He, Lei Tang, Xueling Meng

Chemistry & Biodiversity · 2026-06 · 23 (6)

DOI: 10.1002/cbdv.71420 ↗

At a glance

Journal article in Chemistry & Biodiversity, published online on 2026-06-15. Written by Xiangkai Kong and 4 co-authors. Institution: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizh…. Major MEDLINE topics: Antineoplastic Agents, Tubulin, Colchicine, Tubulin Modulators. Cited 1 times so far (Crossref); 30 references. Funded by: National Natural Science Foundation of China, Guizhou Provincial Major Scientific and Technological Program, High-level Innovative Talents Fund of Guizhou Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Colchicine binding site inhibitors (CBSIs) have developed rapidly in recent years as antitumor agents. Currently, no inhibitors of this specific class are approved for clinical use. In this study, a series of novel 2‐trifluoromethyl‐4‐aminoquinoline derivatives were designed, synthesized, and evaluated for their antiproliferative activity. Among them, compound 8a was the most potent against LNCaP cells with an IC 50 value of 1 nM. Mechanistic studies demonstrated that 8a disrupted tubulin polymerization by binding to the colchicine site of tubulin. Meanwhile, 8a could induce cell apoptosis. Molecular docking indicated that 8a could bind well to the amino acid residues in microtubule protein cavities. Overall, these findings suggested that compound 8a could be a promising antitumor agent targeting the tubulin colchicine binding site.

Subjects

MeSH terms (MEDLINE)

Antineoplastic AgentsTubulinColchicineTubulin ModulatorsQuinolinesDrug DesignHumansBinding SitesMolecular Docking SimulationCell ProliferationStructure-Activity RelationshipDrug Screening Assays, AntitumorCell Line, TumorApoptosisMolecular StructureDose-Response Relationship, Drug

Author keywords

antiproliferative activityantitumormolecular dockingsynthesistubulin polymerization inhibitors

Substances

Antineoplastic AgentsTubulinColchicineTubulin ModulatorsQuinolines

Authors and institutions

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine & School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China.
  • Guizhou Provincial Key Laboratory of Innovation and Manufacturing for Pharmaceuticals, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guiyang, P.R. China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Natural Products Research Center of Guizhou Province, Guizhou Medical Univer…

Funding

  • National Natural Science Foundation of China
  • Guizhou Provincial Major Scientific and Technological Program
  • High-level Innovative Talents Fund of Guizhou Province
  • Department of Science and Technology of Guizhou Province
  • the Project of Health Commission of Guizhou Province
  • Guizhou Medical University
  • Guizhou Provincial Education Department Youth Science and Technology Talent Development Project
  • Guizhou Provincial Science and Technology Department

Cite

APA

Kong, X., Su, Y., He, S., Tang, L., & Meng, X. (2026). Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site. Chemistry & Biodiversity, 23(6). https://doi.org/10.1002/cbdv.71420

Vancouver

Kong X, Su Y, He S, Tang L, Meng X. Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site. Chemistry & Biodiversity. 2026;23(6). doi:10.1002/cbdv.71420

BibTeX
@article{Kong2026,
  author = {Kong, Xiangkai and Su, Yu and He, Siyu and Tang, Lei and Meng, Xueling},
  title = {Anticancer Activity of Novel Trifluoromethylquinoline Derivatives Designed to Target the Tubulin Colchicine Binding Site},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {6},
  doi = {10.1002/cbdv.71420}
}
Start for free →